Financhill
Back

Regeneron Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60

REGN
Regeneron Pharmaceuticals, Inc.

Last Price:
$790.34
Seasonality Move:
0.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Regeneron Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 21.7% based on the past 34 years of stock performance.
  • Regeneron Pharmaceuticals, Inc. has risen higher in 17 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Regeneron Pharmaceuticals, Inc. Stock Undervalued?
    The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $803.17. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Regeneron Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Regeneron Pharmaceuticals, Inc. has on average historically risen by 21.7% based on the past 34 years of stock performance.

Regeneron Pharmaceuticals, Inc. Stock Rating

Buy
60
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Is Regeneron Pharmaceuticals, Inc. overpriced?

  • Regeneron Pharmaceuticals, Inc. has risen higher in 17 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Regeneron Pharmaceuticals, Inc. Stock Price History

Is REGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com

52-Week Data

52-Week High:
821.11
52-Week Low:
476.49

Prediction Charts

Market Cap:
84.9B
Price in USD:
803.17
Volume:
974.8K
Beta:
0.93

Technical Analysis

SMA50:
759.85
SMA100:
698.43
SMA200:
628.27
52-Wk Change:
19.12%

Stock Predictions

  • Is Regeneron Pharmaceuticals, Inc. stock public?
    Yes, Regeneron Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Regeneron Pharmaceuticals, Inc. stock quote today?
    The Regeneron Pharmaceuticals, Inc. stock price is 803.17 USD today.
  • How to buy Regeneron Pharmaceuticals, Inc. stock online?
    You can buy Regeneron Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-27 762.47 771.25 776.25 761.50
Jan-28 765.15 751.13 766.99 747.57
Jan-29 755.73 749.44 755.73 742.80
Jan-30 753.96 741.45 774.37 735.61
Feb-2 732.92 755.02 763.56 731.51
Feb-3 745.53 759.18 773.72 742.74
Feb-4 765.80 775.06 779.78 765.21
Feb-5 777.83 766.63 790.00 760.00
Feb-6 769.63 785.51 786.99 764.78
Feb-9 783.17 780.28 790.00 775.50
Feb-10 779.73 754.91 781.40 753.10
Feb-11 750.85 778.97 781.42 745.07
Feb-12 784.80 783.65 796.72 774.72
Feb-13 788.92 803.17 806.18 785.00

Regeneron Pharmaceuticals, Inc. Earnings

Regeneron Pharmaceuticals, Inc. Earnings Report: Per Share Regeneron Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Regeneron Pharmaceuticals, Inc. Forecast Revenue Growth

Regeneron Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $3.91 per share, a decrease next quarter of $0.50 per share, an increase this year of $1.46 per share, and an increase next year of $7.86 per share.

* Regeneron Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.